共 267 条
[31]
Marks RM(2016)Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging HPB (Oxford) 18 296-931
[32]
Ryan A(2017)Disappearing or residual tiny (</=5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: is local treatment required? Eur Radiol 27 3088-263
[33]
Heba ER(2008)Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 118-236
[34]
Tillman BG(2012)Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases Eur Radiol 22 864-1113
[35]
Gorman JD(2016)ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents Eur Radiol 26 921-299
[36]
Hru JM(2019)Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update Clin Mol Hepatol 25 245-370
[37]
Besa C(2018)EASL clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 69 182-61
[38]
Lewis S(2019)Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update Hepatol Res 49 1109-260
[39]
Pandharipande PV(2019)2018 Korean Liver Cancer Association-National Cancer Center Korea Practice guidelines for the management of hepatocellular carcinoma Gut Liver 13 227-12
[40]
Canellas R(2017)Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Hepatol Int 11 317-90